Mahamaya Lifesciences Ltd
₹181.00▲ +3.35 (+1.89%)
MAHALIFE·BSE·Chemicals
Market Cap
422.93 Cr
PE Ratio
25.64
Volume
13,200
Day High - Low
182.45 - 180.25
52W High-Low
205.05 - 111.00
₹181.00▲ +3.35 (+1.89%)
Market Cap422.93 Cr
PE Ratio25.64
Volume13,200
Day High - Low182.45 - 180.25
52W High-Low205.05 - 111.00
Mahamaya Lifesciences Ltd (MAHALIFE): company summary
The company's business is improving, with annual revenue rising 24.6% and annual net profit rising 27.1%.
Mahamaya Lifesciences Ltd (MAHALIFE) is a micro-cap Chemicals company valued at ₹423 crore operating in Pesticides & Agrochemicals on the NSE and BSE.
- Recent price move
- Mahamaya Lifesciences Ltd last traded at ₹181, modestly up 1.89% on the day.
- Financial performance
- The company's business is improving, with annual revenue rising 24.6% and annual net profit rising 27.1%. The latest quarter showed revenue of ₹166 crore and net profit of ₹8 crore, which is flat compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 25.6 times earnings, 3.51 times book value.
- Things to watch
- The stock is 13.4% below its 52-week high. Promoter holding is 56.35%, which is flat compared to the previous quarter.
- Where it stands
- The company's revenue and net profit have grown significantly over the past three years, with profit growing at a faster rate. The stock is currently 13.4% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
13.55%
Average
P/E
25.64x
Fair
Debt / Equity
0.74
Moderate
Industry
Chemicals
Pesticides & Agrochemicals
Overall View
Mixed
Price performance
Day₹180.25
₹182.45
52W₹111.00
₹205.05
DocStoX take
Supported by growth (8.5) and momentum (7.5), but held back by valuation (2.9). Growth looks strong at 8.5, but that is offset by valuation at 2.9. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.6
/10
Fair
Quality
Modest
ROE 13.6%
Valuation
Expensive
P/E 25.6×
Growth
Strong
Revenue +33.9% 3Y CAGR
Risk
Moderate
D/E 0.74
Momentum
Strong
74% of 52-week range
At a glance
Market Cap
₹423 Cr
52W High / Low
₹205 / ₹111
Dividend Yield
0.00%
Promoter Holding
56.35%
EPS (TTM)
₹7.06
Book Value
₹52.10
Key highlights
- Profit compounding 60% a year
- Revenue compounding 34% a year
- Profitable in all of the last 5 years
- Small ₹423 cr company — thinner liquidity
3 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Pesticides & Agrochemicals
Explore Mahamaya Lifesciences Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Mahamaya Lifesciences Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Mahamaya Lifesciences Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing